Trillium Therapeutic (TRIL)
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -55.91M | -59.35M | -38.08M | -32.87M | -34.75M | |||
| Depreciation Amortization | 292.00K | 590.00K | 610.00K | 2.44M | 3.62M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | -5.43M | -100.00K | 1.99M | -1.32M | 5.74M | |||
| Taxes Paid | N/A | 20.00K | 10.00K | N/A | N/A | |||
| Other non cash items | 13.59M | 36.13M | 10.73M | 1.29M | 4.54M | |||
| OPERATING CASH FLOW | -47.46M | -22.73M | -24.75M | -30.46M | -20.84M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -320.00K | 0.00 | -320.00K | -60.00K | -360.00K | |||
| Other Investing Activity | -102.50M | -35.48M | 9.99M | 23.71M | -43.92M | |||
| INVESTING CASH FLOW | -102.82M | -35.48M | 9.67M | 23.65M | -44.29M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -70.00K | -90.00K | -100.00K | |||
| Stock Issued/Repurchased | 6.15M | 290.91M | 13.88M | 0.00 | 48.32M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 6.15M | 290.91M | 13.81M | -90.00K | 48.22M | |||
| Exchange Rate Effect | 120.00K | 330.00K | 540.00K | -290.00K | -140.00K | |||
| CHANGE IN CASH | -144.01M | 233.03M | -730.00K | -7.19M | -17.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -47.46M | -22.73M | -24.75M | -30.46M | -20.84M | |||
| Capital Expenditure | -320.00K | 0.00 | -320.00K | -60.00K | -360.00K | |||
| FREE CASH FLOW | -47.78M | -22.73M | -25.07M | -30.52M | -21.20M | |||
All data in USD